APA (7th ed.) Citation

AM, E., S, S., M, S., A, T., WH, K., J, M., . . . Santinami, M. (2008). Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: Final results of EORTC 18991, a randomised phase III trial. Lancet, 372(9633), 117. https://doi.org/10.1016/S0140-6736(08)61033-8

Chicago Style (17th ed.) Citation

AM, Eggermont, et al. "Adjuvant Therapy with Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial." Lancet 372, no. 9633 (2008): 117. https://doi.org/10.1016/S0140-6736(08)61033-8.

MLA (9th ed.) Citation

AM, Eggermont, et al. "Adjuvant Therapy with Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial." Lancet, vol. 372, no. 9633, 2008, p. 117, https://doi.org/10.1016/S0140-6736(08)61033-8.